Literature DB >> 12739771

Cell handling, membrane-binding properties, and membrane-penetration modeling approaches of pivampicillin and phthalimidomethylampicillin, two basic esters of ampicillin, in comparison with chloroquine and azithromycin.

Hugues Chanteux1, Isabelle Paternotte, Marie-Paule Mingeot-Leclercq, Robert Brasseur, E Sonveaux, Paul M Tulkens.   

Abstract

PURPOSE: The purpose of this work was to examine and understand the cellular pharmacokinetics of two basic esters of ampicillin, pivaloyloxymethyl (PIVA) and phthalimidomethyl (PIMA), in comparison with lysosomotropic drugs (chloroquine, azithromycin).
METHODS: Cell culture studies (J774 macrophages) were undertaken to study uptake and release kinetics and to assess the influence of concentration, pH, proton ionophore (monensin), and MRP and P-gp inhibitors (probenecid, gemfibrozil, cyclosporin A, GF 120918). Equilibrium dialysis with liposomes were performed to directly asses the extent of drug binding to bilayers. Conformational analysis modeling of the drug penetration in bilayers was conducted to rationalize the experimental observations.
RESULTS: PIVA and PIMA showed properties in almost complete contrast with those of chloroquine and azithromycin, i.e., fast apparent accumulation and fast release at 4 degrees C as well as at 37 degrees C, saturation of uptake (apparent Kd 40 microM), no influence of monensin, MRP, or P-gp inhibitors; tight binding to liposomes (Kd approx. 40 microM); and sharp increase in calculated free energy when forced in the hydrophobic domain.
CONCLUSIONS: Although they are weak organic bases, PIVA and PIMA show none of the properties of lysosomotropic agents. We hypothesize that they remain locked onto the pericellular membrane and may never penetrate cells as such in significant amounts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739771     DOI: 10.1023/a:1023203017300

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

Review 1.  Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.

Authors:  R P Mason; D G Rhodes; L G Herbette
Journal:  J Med Chem       Date:  1991-03       Impact factor: 7.446

Review 2.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies.

Authors:  J P Montenez; F Van Bambeke; J Piret; A Schanck; R Brasseur; P M Tulkens; M P Mingeot-Leclercq
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

Review 4.  Antibiotic efflux pumps.

Authors:  F Van Bambeke; E Balzi; P M Tulkens
Journal:  Biochem Pharmacol       Date:  2000-08-15       Impact factor: 5.858

5.  Temperature dependence of the acid dissociation constants of chloroquine.

Authors:  V Ferrari; D J Cutler
Journal:  J Pharm Sci       Date:  1987-07       Impact factor: 3.534

Review 6.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

7.  Fluorometric analysis of ampicillin in biological fluids.

Authors:  W J Jusko
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

8.  Clinical pharmacology of pivampicillin.

Authors:  E L Foltz; J W West; I H Breslow; H Wallick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

Authors:  F Hyafil; C Vergely; P Du Vignaud; T Grand-Perret
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

10.  Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

Authors:  D E Rudin; P X Gao; C X Cao; H C Neu; S C Silverstein
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  6 in total

1.  Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.

Authors:  Hugues Chanteux; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Cells on pores: a simulation-driven analysis of transcellular small molecule transport.

Authors:  Xinyuan Zhang; Nan Zheng; Peng Zou; Huaning Zhu; Juan P Hinestroza; Gus R Rosania
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

3.  Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.

Authors:  Niklas Lindegardh; Warunee Hanpithakpong; Benjamas Kamanikom; Jeremy Farrar; Tran Tinh Hien; Pratap Singhasivanon; Nicholas J White; Nicholas P J Day
Journal:  Bioanalysis       Date:  2011-01       Impact factor: 2.681

4.  Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.

Authors:  Jean-Michel Michot; Cristina Seral; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.

Authors:  Françoise Van Bambeke; Stéphane Carryn; Cristina Seral; Hugues Chanteux; Donatienne Tyteca; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment.

Authors:  Tingsheng Lin; Qing Zhang; Ahu Yuan; Baojun Wang; Feifei Zhang; Yuanzhen Ding; Wenmin Cao; Wei Chen; Hongqian Guo
Journal:  Theranostics       Date:  2020-06-19       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.